Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 36Active not recruiting 24Completed 17Terminated 10Not yet recruiting 6Withdrawn 5Unknown 2Approved for marketing 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 76Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 46Epirubicin 46Letrozole 42pyrotinib 40Fulvestrant 36Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 31exemestane 27Anastrozole 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 19Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × abemaciclib × Clear all
NCT05464173 2024-01-22

CINDERELLA

Fudan University

Phase 1/2 Unknown
44 enrolled
Breast

Breast Neoplasms

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Blokhin's Russian Cancer Research Center

Unknown
1,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡